Literature DB >> 15731379

Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.

Matthew C Lee1, Jinxia Deng, James M Briggs, Yong Duan.   

Abstract

HIV-1 integrase is one of the three essential enzymes required for viral replication and has great potential as a novel target for anti-HIV drugs. Although tremendous efforts have been devoted to understanding this protein, the conformation of the catalytic core domain around the active site, particularly the catalytic loop overhanging the active site, is still not well characterized by experimental methods due to its high degree of flexibility. Recent studies have suggested that this conformational dynamics is directly correlated with enzymatic activity, but the details of this dynamics is not known. In this study, we conducted a series of extended-time molecular dynamics simulations and locally enhanced sampling simulations of the wild-type and three loop hinge mutants to investigate the conformational dynamics of the core domain. A combined total of >480 ns of simulation data was collected which allowed us to study the conformational changes that were not possible to observe in the previously reported short-time molecular dynamics simulations. Among the main findings are a major conformational change (>20 A) in the catalytic loop, which revealed a gatinglike dynamics, and a transient intraloop structure, which provided a rationale for the mutational effects of several residues on the loop including Q(148), P(145), and Y(143). Further, clustering analyses have identified seven major conformational states of the wild-type catalytic loop. Their implications for catalytic function and ligand interaction are discussed. The findings reported here provide a detailed view of the active site conformational dynamics and should be useful for structure-based inhibitor design for integrase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731379      PMCID: PMC1305464          DOI: 10.1529/biophysj.104.058446

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  41 in total

Review 1.  Structure-based inhibitor design targeting HIV-1 integrase.

Authors:  I-Jen Chen; Nouri Neamati; Alexander D MacKerell
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

2.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

3.  Discovery of a novel binding trench in HIV integrase.

Authors:  Julie R Schames; Richard H Henchman; Jay S Siegel; Christoph A Sotriffer; Haihong Ni; J Andrew McCammon
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

4.  Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.

Authors:  B Oliva; P A Bates; E Querol; F X Avilés; M J Sternberg
Journal:  J Mol Biol       Date:  1998-06-26       Impact factor: 5.469

5.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

6.  Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.

Authors:  N Tsurutani; M Kubo; Y Maeda; T Ohashi; N Yamamoto; M Kannagi; T Masuda
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro.

Authors:  M Drelich; R Wilhelm; J Mous
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration.

Authors:  L I Lobel; J E Murphy; S P Goff
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Targeting retroviral integration.

Authors:  F Bushman
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

10.  Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

Authors:  P M Cannon; W Wilson; E Byles; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more
  22 in total

1.  Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.

Authors:  Prem Raj B Joseph; Jose M Sarmiento; Anurag K Mishra; Sandhya T Das; Roberto P Garofalo; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

2.  Solution conformation and dynamics of the HIV-1 integrase core domain.

Authors:  Nicholas C Fitzkee; James E Masse; Yang Shen; David R Davies; Ad Bax
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

3.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs.

Authors:  Akram Alian; Sarah L Griner; Vicki Chiang; Manuel Tsiang; Gregg Jones; Gabriel Birkus; Romas Geleziunas; Andrew D Leavitt; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

5.  Differential impact of resistance-associated mutations to protease inhibitors and nonnucleoside reverse transcriptase inhibitors on HIV-1 replication capacity.

Authors:  Szu-Min Hsieh; Sung-Ching Pan; Sui-Yuan Chang; Chien-Ching Hung; Wang-Huei Sheng; Mao-Yuan Chen; Shan-Chwen Chang
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-15       Impact factor: 2.205

6.  Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.

Authors:  S Kehlenbeck; U Betz; A Birkmann; B Fast; A H Göller; K Henninger; T Lowinger; D Marrero; A Paessens; D Paulsen; V Pevzner; R Schohe-Loop; H Tsujishita; R Welker; J Kreuter; H Rübsamen-Waigmann; F Dittmer
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Proline substitution of dimer interface β-strand residues as a strategy for the design of functional monomeric proteins.

Authors:  Prem Raj B Joseph; Krishna Mohan Poluri; Pavani Gangavarapu; Lavanya Rajagopalan; Sandeep Raghuwanshi; Ricardo M Richardson; Roberto P Garofalo; Krishna Rajarathnam
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

8.  A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.

Authors:  Cláudio Nahum Alves; Sergio Martí; Raquel Castillo; Juan Andrés; Vicent Moliner; Iñaki Tuñón; Estanislao Silla
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

9.  The role of oligomerization and cooperative regulation in protein function: the case of tryptophan synthase.

Authors:  M Qaiser Fatmi; Chia-en A Chang
Journal:  PLoS Comput Biol       Date:  2010-11-11       Impact factor: 4.475

10.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.